RT Journal Article
SR Electronic
T1 Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003959
DO 10.1136/jitc-2021-003959
VO 10
IS 3
A1 Anderson, Kristin G
A1 Oda, Shannon K
A1 Bates, Breanna M
A1 Burnett, Madison G
A1 Rodgers Suarez, Magdalia
A1 Ruskin, Susan L
A1 Greenberg, Philip D
YR 2022
UL http://jitc.bmj.com/content/10/3/e003959.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.